- Chart
- Upturn Summary
- Highlights
- Valuation
- About
ALT5 Sigma Corporation (ALTS)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/16/2025: ALTS (4-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $18
1 Year Target Price $18
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 658.6% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 238.65M USD | Price to earnings Ratio - | 1Y Target Price 18 |
Price to earnings Ratio - | 1Y Target Price 18 | ||
Volume (30-day avg) 1 | Beta 1.6 | 52 Weeks Range 1.22 - 10.95 | Updated Date 12/16/2025 |
52 Weeks Range 1.22 - 10.95 | Updated Date 12/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.94 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -74.89% | Operating Margin (TTM) -32.85% |
Management Effectiveness
Return on Assets (TTM) -5.66% | Return on Equity (TTM) -44.8% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 196715148 | Price to Sales(TTM) 7.47 |
Enterprise Value 196715148 | Price to Sales(TTM) 7.47 | ||
Enterprise Value to Revenue 8.98 | Enterprise Value to EBITDA -1.27 | Shares Outstanding 124946728 | Shares Floating 100472253 |
Shares Outstanding 124946728 | Shares Floating 100472253 | ||
Percent Insiders 12.44 | Percent Institutions 34.22 |
About ALT5 Sigma Corporation
Exchange NASDAQ | Headquaters Las Vegas, NV, United States | ||
IPO Launch date 1991-11-07 | Acting CEO, Chairman, President, Corporate Secretary & Treasurer Mr. Tony Isaac | ||
Sector Technology | Industry Software - Application | Full time employees 10 | Website https://alt5sigma.com |
Full time employees 10 | Website https://alt5sigma.com | ||
ALT5 Sigma Corporation, together with its subsidiaries, provides blockchain-powered technologies worldwide. It operates through Fintech and Biotechnology segments. The company engages in the tokenization, trading, clearing settlement, payment, and safe keeping of digital assets. Its products include ALT 5 Prime, an electronic over-the-counter trading platform for the buying and selling of digital assets; and ALT 5 Pay, a crypto-currency payment gateway that enables merchants to accept and make crypto currency payments or integrate the payment platform into their application. The company is also involved identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies for the treatment of pain and addiction. In addition, it develops JAN 101, an oral and sustained-release pharmaceutical composition of sodium nitrite that has completed Phase 2a clinical trial to treat peripheral arterial disease and pain; and JAN123, a formulation of low-dose naltrexone for the treatment of chronic regional pain syndrome. The company was formerly known as JanOne Inc. and changed its name to ALT5 Sigma Corporation in July 2024. ALT5 Sigma Corporation was founded in 1976 and is based in Las Vegas, Nevada.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

